ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,032.71
0.93%
US Tech 100
21,368.00
1.37%
Dow Jones
42,540.95
0.81%
Brent Oil
72.455
-3.22%
Bitcoin
107,788.81
2.11%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Iterum Therapeutics PLC (ITRM)

  7. Iterum Therapeutics PLC (ITRM) News

Iterum Therapeutics PLC

Iterum Therapeutics PLC (ITRM)

NASDAQ
1.005
0.0141
( 1.42% )
Updated: 12:56:59
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

ITRM News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
June 11 2025
ITRM (1.42%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 13 2025
ITRM (1.42%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
ITRM (1.42%)

Form 8-K - Current report
Edgar (US Regulatory)
April 29 2025
ITRM (1.42%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
March 18 2025
ITRM (1.42%)

Form 8-K - Current report
Edgar (US Regulatory)
March 10 2025
ITRM (1.42%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
February 20 2025
ITRM (1.42%)

Form 8-K - Current report
Edgar (US Regulatory)
February 14 2025
ITRM (1.42%)

ITRM Discussion

View Posts
mrsmeg3 mrsmeg3 3 weeks ago
There is discussion on ST that Eversana has job postings for 2 DSMs in areas with high ESBL prevalence.
👍️0
Harbor6460 Harbor6460 3 weeks ago
Hows that going
👍️0
Klinsmann Klinsmann 3 months ago
Not yet. But boom to come imo 
👍️0
just Scottie just Scottie 3 months ago
BOOM 💥
👍️0
Klinsmann Klinsmann 3 months ago
I remain patient! It's about to happen, BO and explosion 💥 
👍️ 1
Monksdream Monksdream 3 months ago
ITRM under $2


👍️0
Klinsmann Klinsmann 6 months ago
Huh? Whatever you say... 
this stock is primed for a huge breakout soon. Chart beauty, and buyout news is just pending. They won't sell such a premium product for chump change. 
👍️ 1 🥳 1
KIPK KIPK 6 months ago
With EX pumping here ITRM will follow OTLK imo
👍️0
Klinsmann Klinsmann 6 months ago
100%! The approved drug is worth 300-500 million, and maybe this is even a conservative figure. Just look at the market cap and connect the dots... Have a nice weekend
👍️ 1 🤩 1
glenn1919 glenn1919 6 months ago
ITRM....................https://stockcharts.com/h-sc/ui?s=ITRM&p=W&b=5&g=0&id=p86431144783
👍️0
just Scottie just Scottie 6 months ago
Ya think it can really go that high?
👍️0
Klinsmann Klinsmann 6 months ago
It depends. The fda approval makes this stock worth more than 10$. Not sure when book value and reality are going to match...
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
YEAH NO...BIT LATE SON EEARLY BIRD GETS THE WORM
👍️0
madras50 madras50 6 months ago
there still time to jump on this or you think there is a pullback coming?
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
ITRM MONSTER
👍️0
glenn1919 glenn1919 6 months ago
ITRM...................................https://stockcharts.com/h-sc/ui?s=ITRM&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
ITRM BREAK OUT
👍 1
Klinsmann Klinsmann 6 months ago
I know! And that could mean 15-20$. But most don´t even have the patience to hold until eow and are not able to stand a red day on the long way up and away...
👍️0
exwannabe exwannabe 6 months ago
Not much patience needed. This will be likely be over before Spring.
👍️0
Klinsmann Klinsmann 6 months ago
This stock is going to really bust! Most don't have that needed patience...
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
ITRM GAPPING AS WE APPROACH BREAK OUT...PLAY WITH CAUTION
👍️0
just Scottie just Scottie 6 months ago
If I’m not in a stock it busts out
If I’m in it tanks is my usual scenario
👍️0
Klinsmann Klinsmann 6 months ago
In the end no matter what people on message boards say. The fundamentals in here are plain and simple great! I expect it to really astonish people soon - esp. when you're not in 😉
👍️0
TrendTrade2016 TrendTrade2016 6 months ago
ITRM BREAK OUT PLAY FDA BIO MONTHS AGO
👍 1
exwannabe exwannabe 6 months ago
Huh? No need to pump! FDA approval is a given fact!
Just ignore KIPK.

He is pissed off on another stock (NWBO, where he is banned on this board) about my negative posts. So he follows me around like a stalker and posts idiotic comments on any stock I discuss.
👍️ 1
Klinsmann Klinsmann 7 months ago
Huh? No need to pump! FDA approval is a given fact!
👍️0
KIPK KIPK 7 months ago
OTLK that EX been pumping just crashed; failed trial
👍️0
KIPK KIPK 7 months ago
Beware of paid pumper/basher EX....................
👍️0
Klinsmann Klinsmann 7 months ago
But the final number gonna be 5-10 times above our market cap rn around 2$...
👍️0
exwannabe exwannabe 7 months ago
The game plan is to monetize by selling off either rights to the drug or the company. Either way all is over and all we can do is wait on the final number.
👍️0
just Scottie just Scottie 7 months ago
Sounds about right my friend
👍️ 1
Klinsmann Klinsmann 7 months ago
Never left the boat! Added lows, no hurry to sell my shares. Expect 10$+
👍️0
just Scottie just Scottie 7 months ago
Where is everyone lol
A buyout is coming to town
👍️0
just Scottie just Scottie 8 months ago
Very important drug. Big pharma like Pfizer may come calling or has called already
👍️ 1
Klinsmann Klinsmann 8 months ago
Gonna be a multi day run imo
👍️0
glenn1919 glenn1919 8 months ago
ITRM..................https://stockcharts.com/h-sc/ui?s=ITRM&p=W&b=5&g=0&id=p86431144783
👍 1 🚀 1
just Scottie just Scottie 8 months ago
Excellent
👍 1 🚀 1
exwannabe exwannabe 8 months ago
Label is about as expected. They did recommend culture testing (to insure proper agent is used for specific bug), bt did so in a general way that implies it is universal. No black box (was mentioned as possible to warn against creating resistence).
👍 1 💯 1
tw0122 tw0122 8 months ago
Stuck in this halt but up 13% not  complaining 
1.40+ 20%
👍 1 🚀 1
just Scottie just Scottie 8 months ago
Agree
👍 1 🔥 1
tw0122 tw0122 8 months ago
Big Pharma bribes, rules and runs the FDA its the American way of doing business meanwhiles urinary tract infection a big markets
👍 1 🚀 1
just Scottie just Scottie 8 months ago
Any strength shown is met with selling
👍️0
just Scottie just Scottie 8 months ago
Plus it’s not right to tie the company’s hands and restrict their ability to sell a product which will actually help people by having specific instructions on labels.

I tend to think if this was a big company such as Merck or Pfizer we wouldn’t have this issue
👍️0
just Scottie just Scottie 8 months ago
Yes it sounds like there will be some stipulations the FDA will enact.
It’s a shame! I understand the bug resistance aspect being in the medical field tho.

Im still a believer in the MD’S being the problem of which they don’t want to take full responsibility.
The FDA shouldn’t punish a biotech company for developing a new product which is needed. The AMA needs to do a better job of educating the educated 😆
👍️0
exwannabe exwannabe 8 months ago
I went through the ADCOM material a few weeks ago, but mainly from the pov of understanding what the FDA analysis was. I am very comfortable the FDA is willing to bless sulo as being safe and effective, the only open question is how to try to restrict use to avoid resistance.

Replaying it and listening more closely to the details of the discussion of creating resistance, I can understand how this is a tough issue to tackle.

The proposed label by ITRM (designated susceptible micro-organisms) is clearly a non-starter. Nobody at the ADCOM could even say what that means, and even if they could, the family doc is not about to call for a several hundred dollar test just to prescribe a cheap pill that almost always "works". Alternatives such as use after failure or use for resistant bugs had no supportable data,. Certainly a problem for the FDA, but they will find some label that expresses the concern.

I would be certain they will exclude use as a step down following IV treatments. I suspect they will somehow say use for cases where the doctor finds treatment via augmenten is not suitable.

I would not at all be surprised to see the FDA go off the farm and issue a black box against abuse due to risk of generating carbo-penum resistant bugs.

I wold be certain there will be a REMS and/or post approval study on these issues.

On the broader issue of antibiotic management, I was encouraged everybody took it seriously. I was discouraged that most all felt the community docs will broadly ignore it and take the easy way out.

.
👍️0
just Scottie just Scottie 8 months ago
Yes! Cipro and augmentin have been around for a long time.
It will take a while for the bugs to become resistant to this one.
And yes the doctors are the ones that caused this over prescribing. They give it away like candy and use it as a prophylactic after just about every surgery
👍️0
exwannabe exwannabe 8 months ago
For some explanation on that subject, the absurd off-label use of all antibiotics is a huge issue. That is true for all, nothing specific here. Go to most any third world or developing country and you can buy Cirpro for a few bucks for 2 weeks(?) worth, no prescription.

This is what is causing the problem with "super bugs". So yes, the FDA has a concern here.

OTOH, the same thing is why we need more choice in the field of antibiotics. And that is what this is, another choice for bugs that are are resistent to other antibiotics.
👍️0
just Scottie just Scottie 8 months ago
AI Overview
According to recent updates, the FDA appears to be leaning towards approving Sulopenem for the treatment of uncomplicated urinary tract infections (uUTIs), but with significant concerns regarding antimicrobial resistance and the need for careful monitoring through post-marketing surveillance to ensure appropriate usage; the FDA Advisory Committee acknowledged the potential benefit for a subset of patients while emphasizing the importance of managing off-label use and potential impact on antimicrobial resistance if approved.
👍️0
just Scottie just Scottie 8 months ago
Sounds like the drug works well. FDA has to have the appropriate usage on the label it sounds like
👍️0
exwannabe exwannabe 8 months ago
Odds of approval are high, but I would not expect a huge gain.

Maybe up to $2-3 on thumbs up. Certainly down to almost $0 on thumbs down.

Again, I think the odds are good, so a good bet. Just think this is not one of those huge jumps you see on some drug approvals.
👍️0

Your Recent History

NASDAQ
ITRM
Iterum Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads